Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

IMM-101 × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Dermatologic 4 Sarcoma 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

Radiotherapy 220 Cyclophosphamide 211 Doxorubicin 210 Temozolomide 182 Ifosfamide 121 Filgrastim 111 Imatinib Mesylate 103 Etoposide 101 Vincristine 92 Gemcitabine 88 Bevacizumab 82 Magnetic Resonance Spectroscopy 79 Irinotecan 79 pembrolizumab 75 Radiation 69 Carboplatin 65 pazopanib 61 Methotrexate 61 fludarabine phosphate 58 Cisplatin 58 Peripheral Blood Stem Cell Transplantation 57 Nivolumab 57 Surgical Procedures, Operative 56 Specimen Handling 55 Trabectedin 52 Docetaxel 50 Biopsy 50 Busulfan 49 Melphalan 46 Paclitaxel 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡